The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

Mtv13  -  mammary tumor virus locus 13

Mus musculus

Synonyms: Mls, Mls-2, Mls2, Mtv-13
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Mtv13

  • Mls phenotypes correlate with the integration of mouse mammary tumor viruses (MTV) in the mouse genome [1].
  • Bacterial toxins constitute the major group of exogenous SAGs, while the mouse mammary tumor virus (MMTV)-encoded Mls molecules represent the endogenous SAGs [2].
  • The majority of endogenous superantigens in the mouse (including the Mls loci) is encoded by mouse mammary tumor proviruses (Mtv) carried in the germline [3].
  • The responses of normal spleen cells to B cell lines that express the defective virus indicated that these lines express a cell surface determinant that shares "superantigenic" properties with some microbial antigens and Mls-like self antigens [4].
  • The Mls gene products, which have long been known for their potent T-cell stimulatory function, have recently come of age through two pivotal discoveries, revealing that they act as superantigens and originate from retroviruses [5].
 

High impact information on Mtv13

  • We report here the Mls 2a/3a mediated elimination of T cells expressing a transgene encoded V beta 3-segment, in T-cell receptor alpha/beta and beta-transgenic mice [6].
  • Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex [7].
  • Immunology. Tolerance, restriction and the Mls enigma [8].
  • The only other potent primary proliferative response known is induced by mixing MHC-identical lymphocytes from strains that differ at the locus termed Mls (ref. 1) (for mixed lymphocyte stimulating), which has been mapped to chromosome 1 [9].
  • It has been proposed that the Mls locus product is a minor antigen recognized in association with self-Ia antigens, a translocated Ia-like element, or a mitogenic molecule found on the surface of antigen presenting cells (APC) [9].
 

Chemical compound and disease context of Mtv13

 

Biological context of Mtv13

  • It stimulates V beta 3+ hybrids and may be linked to Mtv-13 on chromosome 4 [11].
  • Proliferative responses to M locus (Mls) determinants were investigated in vivo by injecting T cell-containing populations intravenously into irradiated H2-identical, Mls-incompatible mice [12].
  • These findings suggest a new concept of the polymorphism and genetics of the Mls system [13].
  • The peripheral level of V beta 3 transcripts vary with MHC and Mls-2 haplotypes [14].
  • Thymic epithelium induces neither clonal deletion nor anergy to Mls 1a antigens [15].
 

Anatomical context of Mtv13

  • Evidence that Mls-2 antigens which delete V beta 3+ T cells are controlled by multiple genes [11].
  • Studies on non-H-2-linked lymphocyte-activating determinants. IV. Ontogeny of the Mls product on murine B cells [16].
  • Proliferation of C3H x CBA hybrid lymphocytes in the spleens of irradiated CBA mice: linkage to the Mls-gene [17].
  • Relative V beta transcript levels in thymus and peripheral lymphoid tissues from various mouse strains. Inverse correlation of I-E and Mls expression with relative abundance of several V beta transcripts in peripheral lymphoid tissues [14].
  • Dendritic cells and thymic B cells were also effective in inducing tolerance even when injected into Mls-, major histocompatibility complex-incompatible, I-E- mice, but only thymic B cells depleted V beta 6-expressing T cells [18].
 

Associations of Mtv13 with chemical compounds

  • Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens [19].
  • A qualitative difference was observed when analyses of inositol phosphate production were performed under optimal conditions of stimulation of the highly responsive T cell hybridoma (FJ8.1): only stimulation with CD3-specific mAb, but not Mls-expressing cells, could induce detectable inositol phosphate production [20].
  • Our studies indicate that the A alpha and E alpha chains can present Mls gene products for the clonal deletion of V beta 6-bearing T cells, and that the A alpha q chain is defective in this process [21].
 

Other interactions of Mtv13

 

Analytical, diagnostic and therapeutic context of Mtv13

  • Since congenic resistant strains were not used, the possibility that the stimulation observed was in fact due to minor transplantation antigens rather than Mls determinants could not be excluded [12].
  • We subsequently presented evidence which indicated that the mixed leukocyte reaction stimulatory products of DBA/2 and CBA/J were controlled by two independently segregating Mls loci [23].
  • METHODS: C3H (H2k, Thy 1.2, Mls 2a) recipients were conditioned with 9.5 gray (Gy) of total body irradiation [24].
  • The role of hemopoietic stem cells and other cell types in the induction and maintenance of immunologic tolerance in the thymus was investigated by intravenous injection of Mls-semi-allogeneic cells into newborn mice less than 24 hr after birth [25].
  • The evolution of Vbeta6-expressing C3H (H2k, Thy 1.2, Mls a-) lymphocytes was investigated in C3H recipients mice pretreated with total body irradiation (TBI) or total lymphoid irradiation (TLI) and infusion of AKR (H2k, Thy 1.1, Mls a+) cells [26].

References

  1. The open reading frames in the 3' long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens. Pullen, A.M., Choi, Y., Kushnir, E., Kappler, J., Marrack, P. J. Exp. Med. (1992) [Pubmed]
  2. Production and characterization of an Mls-1-specific monoclonal antibody. Mohan, N., Mottershead, D., Subramanyam, M., Beutner, U., Huber, B.T. J. Exp. Med. (1993) [Pubmed]
  3. Physiologic expression of two superantigens in the BDF1 mouse. Gollob, K.J., Palmer, E. J. Immunol. (1991) [Pubmed]
  4. A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice. Hügin, A.W., Vacchio, M.S., Morse, H.C. Science (1991) [Pubmed]
  5. Mls genes and self-superantigens. Huber, B.T. Trends Genet. (1992) [Pubmed]
  6. Phenotypic differences between alpha beta versus beta T-cell receptor transgenic mice undergoing negative selection. Berg, L.J., Fazekas de St Groth, B., Pullen, A.M., Davis, M.M. Nature (1989) [Pubmed]
  7. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Kappler, J.W., Staerz, U., White, J., Marrack, P.C. Nature (1988) [Pubmed]
  8. Immunology. Tolerance, restriction and the Mls enigma. Robertson, M. Nature (1988) [Pubmed]
  9. Efficiency of antigen presentation differs in mice differing at the Mls locus. Janeway, C.A., Conrad, P.J., Tite, J., Jones, B., Murphy, D.B. Nature (1983) [Pubmed]
  10. Cessation of autonomous proliferation of mouse lymphoma EL4 by fusion with a T cell line. Kubota, K., Katoh, H. Int. J. Cancer (1990) [Pubmed]
  11. Evidence that Mls-2 antigens which delete V beta 3+ T cells are controlled by multiple genes. Pullen, A.M., Marrack, P., Kappler, J.W. J. Immunol. (1989) [Pubmed]
  12. Activation of T lymphocytes to M locus determinants in vivo. I. Quantitation of T cell proliferation and migration into thoracic duct lymph. Sprent, J., von Boehmer, H. Eur. J. Immunol. (1976) [Pubmed]
  13. Clonal analysis of the Mls system. A reappraisal of polymorphism and allelism among Mlsa, Mlsc, and Mlsd. Abe, R., Ryan, J.J., Hodes, R.J. J. Exp. Med. (1987) [Pubmed]
  14. Relative V beta transcript levels in thymus and peripheral lymphoid tissues from various mouse strains. Inverse correlation of I-E and Mls expression with relative abundance of several V beta transcripts in peripheral lymphoid tissues. Okada, C.Y., Weissman, I.L. J. Exp. Med. (1989) [Pubmed]
  15. Thymic epithelium induces neither clonal deletion nor anergy to Mls 1a antigens. Bandeira, A., Coutinho, A., Burlen-Defranoux, O., Khazaal, I., Coltey, M., Jacquemart, F., Le Douarin, N., Salaün, J. Eur. J. Immunol. (1992) [Pubmed]
  16. Studies on non-H-2-linked lymphocyte-activating determinants. IV. Ontogeny of the Mls product on murine B cells. Ahmed, A., Scher, I., Sell, K.W. Cell. Immunol. (1977) [Pubmed]
  17. Proliferation of C3H x CBA hybrid lymphocytes in the spleens of irradiated CBA mice: linkage to the Mls-gene. Lilliehöök, B. Scand. J. Immunol. (1980) [Pubmed]
  18. Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells. Inaba, M., Inaba, K., Hosono, M., Kumamoto, T., Ishida, T., Muramatsu, S., Masuda, T., Ikehara, S. J. Exp. Med. (1991) [Pubmed]
  19. Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens. Eto, M., Mayumi, H., Tomita, Y., Yoshikai, Y., Nomoto, K. J. Exp. Med. (1990) [Pubmed]
  20. Evidence for quantitative and qualitative differences in functional activation of Mls-reactive T cell clones and hybridomas by antigen or TcR/CD3 antibodies. Gaugler, B., Langlet, C., Martin, J.M., Schmitt-Verhulst, A.M., Guimezanes, A. Eur. J. Immunol. (1991) [Pubmed]
  21. Role of MHC, Mls and TCR in immune tolerance. Anderson, G., David, C. J. Immunogenet. (1989) [Pubmed]
  22. Mls-1 and Mls-2 superantigens do not control susceptibility to collagen-induced arthritis in HI and HII mice. Roger, T., Boudaly, S., Couderc, J., Seman, M. Immunology (1993) [Pubmed]
  23. Multigene control of Mlsc. Click, R.E., Adelmann, A. Immunogenetics (1988) [Pubmed]
  24. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells. Sefrioui, H., Billiau, A.D., Overbergh, L., Rutgeerts, O., Waer, M. Transplantation (1999) [Pubmed]
  25. Neonatal tolerance induction in the thymus to MHC-class II-associated antigens. III. Significance of hemopoietic stem cells for induction and maintenance of Mls tolerance by continuous supply of tolerance-inducing nonlymphocytes. Hosono, M., Hosokawa, T., Kina, T., Katsura, Y. Cell. Immunol. (1987) [Pubmed]
  26. Clonal deletion and clonal anergy in allogeneic bone marrow chimeras prepared with TBI or TLI. Salam, A., Vandeputte, M., Waer, M. Transpl. Int. (1994) [Pubmed]
 
WikiGenes - Universities